Immunosuppressive effects of RT in the TME include an increased infiltration of regulatory T cells (Tregs), M2 tumor-associated macrophages (TAMs), and MDSCs [5], along with the expression of immune checkpoints molecules such as PD1/PDL1, CTLA4, and CD47 on tumor cells [6]. The gene discussed is CTLA4; the disease is neoplasm.